TNF and acute myeloid leukemia: Elevated levels of IL-1β, IL-6, and TNFα in patients with AML and APL further enhance endothelial tissue factor expression, while TNFα suppresses thrombomodulin transcription, promoting hypercoagulability and dysregulation of coagulation.